Cooper et al v. Wyeth, Inc et al, No. 3:2009cv00929 - Document 163 (M.D. La. 2013)

Court Description: ORDER granting 149 Motion for Reconsideration. The Court's Ruling of 03/06/2012, is hereby AMENDED for the reasons set forth above, and Plaintiffs' remaining claims against Defendants PLIVA, Inc. and Watson Laboratories, Inc. for failure to warn under the Louisiana Products Liability Act (LPLA), based on the theories of failure to communicate and update to include an FDA-approved label on their generic drug products are hereby DISMISSED with prejudice. This Ruling has no bearing on Plaintiffs' remaining claims against Defendant, Wyeth LLC, individually and as successor-in-interest to ESI-Lederle, Inc. Signed by District Judge Shelly D. Dick on 12/11/2013. (CGP)

Download PDF
Cooper et al v. Wyeth, Inc et al Doc. 163 Dockets.Justia.com

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.